0.05Open0.05Pre Close0 Volume176 Open Interest15.00Strike Price0.00Turnover161.27%IV45.69%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0562Delta0.0500Gamma206.60Leverage Ratio-0.0176Theta0.0001Rho11.61Eff Leverage0.0016Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet